BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 25820078)

  • 1. Effect of bismuth subgallate on the quality of life in patients undergoing Scopinaro's biliopancreatic diversion.
    Hernández JR; Rizzo JF; Díaz YC; Bubi ED; Cabrillana JM; López-Tomassetti Fernández EM
    Surg Obes Relat Dis; 2015; 11(2):436-41. PubMed ID: 25820078
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Does Bismuth Subgallate Affect Smell and Stool Character? A Randomized Double-Blinded Placebo-Controlled Trial of Bismuth Subgallate on Loop Duodenal Switch Patients with Complaints of Smelly Stools and Diarrhea.
    Zaveri H; Surve A; Cottam D; Medlin W; Richards C; Cottam A; Cottam S
    Obes Surg; 2018 Nov; 28(11):3511-3517. PubMed ID: 29956108
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Biliopancreatic diversion for treatment of morbid obesity: experience in 180 consecutive cases.
    Totté E; Hendrickx L; van Hee R
    Obes Surg; 1999 Apr; 9(2):161-5. PubMed ID: 10340770
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Laparoscopic biliopancreatic diversion: our preliminary experience with 201 consecutive cases.
    Piazza L; Pulvirenti A; Ferrara F; Bellia A; Leanza S; Coco D; Piazza C; Lo Giudice G
    Chir Ital; 2009; 61(2):143-8. PubMed ID: 19536986
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Preliminary results of biliopancreatic diversion in the treatment of morbid obesity. Clinical considerations on 69 patients with a 3-year follow-up].
    Cossu ML; Coppola M; Fais E; Ruggiu M; Noya G
    Minerva Chir; 2000 Apr; 55(4):211-9. PubMed ID: 10859954
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Biliopancreatic diversion for treatment of morbid obesity: experience in 50 cases.
    Noya G; Cossu ML; Coppola M; Tonolo G; Angius MF; Fais E; Ruggiu M
    Obes Surg; 1998 Feb; 8(1):61-6. PubMed ID: 9562489
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Does bismuth subgallate have haemostatic effects in tonsillectomy?
    Sørensen WT; Henrichsen J; Bonding P
    Clin Otolaryngol Allied Sci; 1999 Feb; 24(1):72-4. PubMed ID: 10196655
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Revision of Biliopancreatic Diversion for Side Effects or Insufficient Weight Loss: Codification of a New Procedure.
    Ceriani V; Pinna F; Lodi T; Pontiroli AE
    Obes Surg; 2017 Apr; 27(4):1091-1097. PubMed ID: 28197865
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Jejunal adenocarcinoma after biliopancreatic diversion. Report of a case.
    Cossu ML; Fancellu A; Feo CF; Ginesu GC; Sogos S; Ariu ML; Porcu A
    Obes Res Clin Pract; 2022; 16(3):269-271. PubMed ID: 35562313
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Laparoscopic biliopancreatic diversion for the treatment of morbid obesity: initial experience.
    Paiva D; Bernardes L; Suretti L
    Obes Surg; 2001 Oct; 11(5):619-22. PubMed ID: 11594106
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Bismuth subgallate as a topical hemostatic agent at palatal donor sites.
    Kim SH; Tramontina VA; Papalexiou V; Luczyszyn SM
    Quintessence Int; 2010 Sep; 41(8):645-649. PubMed ID: 20657853
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Activation of Hageman factor (factor XII) by bismuth subgallate, a hemostatic agent.
    Thorisdottir H; Ratnoff OD; Maniglia AJ
    J Lab Clin Med; 1988 Oct; 112(4):481-6. PubMed ID: 3171356
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Severe corneoconjunctival xerosis after biliopancreatic bypass for obesity (Scopinaro's operation).
    Quaranta L; Nascimbeni G; Semeraro F; Quaranta CA
    Am J Ophthalmol; 1994 Dec; 118(6):817-8. PubMed ID: 7977616
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Biliopancreatic diversion with duodenal switch.
    Marceau P; Hould FS; Simard S; Lebel S; Bourque RA; Potvin M; Biron S
    World J Surg; 1998 Sep; 22(9):947-54. PubMed ID: 9717420
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The influence of bismuth subgallate and adrenaline paste upon operating time and operative blood loss in tonsillectomy.
    Callanan V; Curran AJ; Smyth DA; Gormley PK
    J Laryngol Otol; 1995 Mar; 109(3):206-8. PubMed ID: 7745335
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Impact on quality of life, weight loss and comorbidities: a study comparing the biliopancreatic diversion with duodenal switch and the banded Roux-en-Y gastric bypass.
    Duarte MI; Bassitt DP; Azevedo OC; Waisberg J; Yamaguchi N; Pinto Junior PE
    Arq Gastroenterol; 2014; 51(4):320-7. PubMed ID: 25591161
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Biliopancreatic diversion with transient gastroplasty and duodenal switch: long-term results of a multicentric study.
    Pata G; Crea N; Di Betta E; Bruni O; Vassallo C; Mittempergher F
    Surgery; 2013 Mar; 153(3):413-22. PubMed ID: 23122900
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Biliopancreatic Diversion in the Surgical Treatment of Morbid Obesity: Long-Term Results and Metabolic Consequences.
    Bianchi A; Pagan-Pomar A; Jimenez-Segovia M; Martinez-Corcoles JA; Gonzalez-Argenté FX
    Obes Surg; 2020 Nov; 30(11):4234-4242. PubMed ID: 32562130
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Blind loop syndrome after biliopancreatic diversion: a diagnostic challenge.
    Fabry H; Hendrickx L; Van Hee R
    Obes Surg; 2001 Oct; 11(5):643-5. PubMed ID: 11594112
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Bismuth subgallate--its role in tonsillectomy.
    Fenton JE; Blayney AW; O'Dwyer TP
    J Laryngol Otol; 1995 Mar; 109(3):203-5. PubMed ID: 7745334
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.